CR8677A - Derivados de piridoindolona sustituidos en -6, su preparacion, su aplicacion en terapeutica - Google Patents

Derivados de piridoindolona sustituidos en -6, su preparacion, su aplicacion en terapeutica

Info

Publication number
CR8677A
CR8677A CR8677A CR8677A CR8677A CR 8677 A CR8677 A CR 8677A CR 8677 A CR8677 A CR 8677A CR 8677 A CR8677 A CR 8677A CR 8677 A CR8677 A CR 8677A
Authority
CR
Costa Rica
Prior art keywords
piridoindolona
therapeutics
derived
replaced
preparation
Prior art date
Application number
CR8677A
Other languages
English (en)
Inventor
Bernard Bourrie
Pierre Casellas
Paola Ciapetti
Jean Marie Derocq
Samir Jegham
Yvette Muneaux
Camille-George Wermuth
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of CR8677A publication Critical patent/CR8677A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)

Abstract

La presente invencion tiene por objeto compuestos que responden a la formula ( I ), en la que -R1, representa un atomo de hidrogeno, un grupo alquilo (c1-c4) un grupo- (CH2)mOH, un grupo -(CH2)m CN, un grupo -(CH2)mNR9R10-R2 representa un atomo de hidrogeno o un grupo alquilo (c1-c4).
CR8677A 2004-04-21 2006-10-09 Derivados de piridoindolona sustituidos en -6, su preparacion, su aplicacion en terapeutica CR8677A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0404251A FR2869316B1 (fr) 2004-04-21 2004-04-21 Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
CR8677A true CR8677A (es) 2007-08-28

Family

ID=34945552

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8677A CR8677A (es) 2004-04-21 2006-10-09 Derivados de piridoindolona sustituidos en -6, su preparacion, su aplicacion en terapeutica

Country Status (31)

Country Link
US (1) US7812165B2 (es)
EP (1) EP1742947B1 (es)
JP (1) JP4809830B2 (es)
KR (1) KR20070002094A (es)
CN (1) CN100537568C (es)
AR (1) AR048932A1 (es)
AT (1) ATE405565T1 (es)
AU (1) AU2005240816A1 (es)
BR (1) BRPI0510060A (es)
CA (1) CA2562561A1 (es)
CR (1) CR8677A (es)
DE (1) DE602005009166D1 (es)
DK (1) DK1742947T3 (es)
EC (1) ECSP066918A (es)
ES (1) ES2313371T3 (es)
FR (1) FR2869316B1 (es)
HK (1) HK1106223A1 (es)
IL (1) IL178444A0 (es)
MA (1) MA28546B1 (es)
MX (1) MXPA06012127A (es)
MY (1) MY137599A (es)
NO (1) NO20065323L (es)
PL (1) PL1742947T3 (es)
PT (1) PT1742947E (es)
RU (1) RU2364595C2 (es)
TN (1) TNSN06337A1 (es)
TW (1) TW200538114A (es)
UA (1) UA85709C2 (es)
UY (1) UY28864A1 (es)
WO (1) WO2005108398A1 (es)
ZA (1) ZA200608646B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823975B1 (fr) 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
FR2846329B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
US7456193B2 (en) 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2892416B1 (fr) * 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268772A (en) 1968-03-15 1972-03-29 Glaxo Lab Ltd NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
US4263304A (en) * 1978-06-05 1981-04-21 Sumitomo Chemical Company, Limited 7 H-indolo[2,3-c]isoquinolines
SU833971A1 (ru) 1979-07-10 1981-05-30 Ленинградский Химико-Фармацевтическийинститут Способ получени 3-фенил-2-оксо- - КАРбОлиНОВ
FR2595701B1 (fr) * 1986-03-17 1988-07-01 Sanofi Sa Derives du pyrido-indole, leur application a titre de medicaments et les compositions les renfermant
JPH10501686A (ja) 1994-04-13 1998-02-17 ザ ロックフェラー ユニヴァーシティ 神経系の細胞へのｄｎａのａａｖ仲介送達
DE19502753A1 (de) * 1995-01-23 1996-07-25 Schering Ag Neue 9H-Pyrido[3,4-b]indol-Derivate
FR2765582B1 (fr) 1997-07-03 1999-08-06 Synthelabo Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
FR2765581B1 (fr) * 1997-07-03 1999-08-06 Synthelabo Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
CA2326319A1 (en) 1998-04-02 1999-10-14 Neurogen Corporation Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands
IT1313592B1 (it) 1999-08-03 2002-09-09 Novuspharma Spa Derivati di 1h-pirido 3,4-b indol-1-one.
US20020156016A1 (en) 2001-03-30 2002-10-24 Gerald Minuk Control of cell growth by altering cell membrane potentials
FR2823975B1 (fr) * 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
FR2846330B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique
US7456193B2 (en) * 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2846329B1 (fr) * 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
FR2892416B1 (fr) * 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
JP4809830B2 (ja) 2011-11-09
KR20070002094A (ko) 2007-01-04
MA28546B1 (fr) 2007-04-03
FR2869316A1 (fr) 2005-10-28
EP1742947A1 (fr) 2007-01-17
CA2562561A1 (fr) 2005-11-17
NO20065323L (no) 2006-12-08
HK1106223A1 (en) 2008-03-07
ES2313371T3 (es) 2009-03-01
RU2006140998A (ru) 2008-05-27
AR048932A1 (es) 2006-06-14
CN1956986A (zh) 2007-05-02
MXPA06012127A (es) 2007-01-31
US20070129365A1 (en) 2007-06-07
BRPI0510060A (pt) 2007-10-16
FR2869316B1 (fr) 2006-06-02
MY137599A (en) 2009-02-27
IL178444A0 (en) 2007-02-11
JP2007533710A (ja) 2007-11-22
CN100537568C (zh) 2009-09-09
WO2005108398A1 (fr) 2005-11-17
RU2364595C2 (ru) 2009-08-20
DE602005009166D1 (de) 2008-10-02
ZA200608646B (en) 2008-02-27
ATE405565T1 (de) 2008-09-15
AU2005240816A1 (en) 2005-11-17
TW200538114A (en) 2005-12-01
US7812165B2 (en) 2010-10-12
TNSN06337A1 (en) 2008-02-22
UA85709C2 (ru) 2009-02-25
PT1742947E (pt) 2008-11-25
UY28864A1 (es) 2005-11-30
ECSP066918A (es) 2007-01-26
PL1742947T3 (pl) 2009-01-30
DK1742947T3 (da) 2009-01-05
EP1742947B1 (fr) 2008-08-20

Similar Documents

Publication Publication Date Title
AR110313A2 (es) Derivados de tiazol-2-il-pirrolidina
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
TW200730490A (en) Photoactive compounds
ES2531190T3 (es) Método para producir un compuesto de 4-oxoquinolina
BRPI0520870B8 (pt) compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila
CR11596A (es) Derivados de urea de tetrahidroquinoxalina, su preparacion y su aplicacion en terapeutica
EA200801959A1 (ru) Высокоразветвленный полипропилен
TW200613256A (en) Photoactive compounds
CY1110064T1 (el) Παραγωγα φαινυλ-πιπεραζινης ως αναστολεις επαναπροσληψης σεροτονινης
TW200626559A (en) Anilino-pyrimidine analogs
CY1112011T1 (el) Παραγωγα αζαδικυκλο (3.1.0) εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης
CO6270314A2 (es) Un derivado de y--amino acido biciclico que tiene una actividad como ligando (alfa)2(omega)
CR9066A (es) Nuevos derivados de aminopirimidina que tiene accion inhibitoria selectiva de la aurora a
CR9602A (es) Nuevos derivados de 2,4-dianilinpirimidinas, su preparacion, como medicamentos, composiciones farmaceuticas y particularmente como inhibidores de ikk
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
UY31506A1 (es) Derivados de indolinona y procedimiento para su preparacion
ES2571483T3 (es) Producto intermedio para producir un éster de ácido sulfónico cíclico
UY30009A1 (es) Compuestos benzoilpirazol y herbicidas que los contienen
DK1948606T3 (da) 3, 5-disubstituerede phenyl-piperidiner som modulatorer af dopaminneurotransmission
CR20120261A (es) Derivados de piridino-piridinonas, su preparación y su aplicación en terapéutica
AR070485A1 (es) Compuestos derivados de azetidinas, su preparacion y su aplicacion en terapeutica
CR9495A (es) Composicion en emulsion estable
CR9565A (es) Derivados del 4,5-diarilpirrol, su preparacion y su aplicacion en terapeutica
CR20110360A (es) Derivados de 2-piridin-2-il-pirazol-3-(2h)-ona, su preparacion y su aplicacion en terapeutica
CR8677A (es) Derivados de piridoindolona sustituidos en -6, su preparacion, su aplicacion en terapeutica

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)